ValueScreener company report

Rentokil Initial plc (RTO)

Name: Rentokil Initial plc (RTO) filed financial figures
Creator: ValueScreener

NYSE / Industrials / Specialty Business Services

Share price

20.82 USD Market dataClose of Oct 15, 2026

Market capitalisation

10.48B USD Market dataClose of Oct 15, 2026

Market data: Oct 15, 2026
Filed accounts: FY2025, filed Mar 25, 2026
Ratios computed: Oct 15, 2026
Filed years: 3, FY2023 to FY2025

Four kinds of sourceSEC filingCompany statementMarket dataComputedWhat each means

SEC filingFiled with the SEC: Read from a statement the company filed with the SEC, with the form, fiscal year, filing date and accession beside it.
Company statementCompany statement: What the company says about itself in a filing: an 8-K item, the auditor, its own segment names.
Market dataMarket data: Prices, market value and what analysts publish, with the date they are as of.
ComputedComputed by ValueScreener: Worked out by us from the other three, with the inputs and the formula one press away. A score is a research output, not a rating or a recommendation.

Reading

1 of 10

Overview

What the business is, what it costs, and how it reads on four questions.

Market dataSEC filingComputed

Quality

Return on invested capital, after tax

n/a Computed

From the FY2025 filing

Why n/a

No annual statement of this kind is on file for this fiscal year.

Read quality

Financial strength

Debt to equity

n/a Computed

Why n/a

No annual statement of this kind is on file for this fiscal year.

Read financial strength

Valuation

Price to earnings

22.29x Computed

FY2025 accounts, priced at the latest close

Read valuation

Cash generation

Free cash flow yield

7.3% Computed

FY2025 accounts, priced at the latest close

Read cash generation

Revenue and net income, by fiscal year

Revenue Net income10 fiscal years; a year whose statement names no SEC filing is market data, and the table in Filings says which.

Named tests met: 1 of 30 Which tests

The business, and the score behind its five axes

The reading, in brief

Is it cheap

Price to earnings is 22.29x at the close of 2026-10-15 on FY2025 figures; the lines are 15.00x (Graham's defensive ceiling) and, by market convention, 10.00x, 25.00x and 40.00x, and this sits between 15.00x and 25.00x.

Today, against the Industrials sector (412 companies), 22.29x sits at the 43rd percentile; the middle half of that group runs from 15.04x to 38.40x.

Is it good

Return on invested capital for Rentokil Initial plc in FY2025: n/a. No annual statement of this kind is on file for this fiscal year.

Is it safe

Interest coverage was 2.34x in FY2025, in the band labelled "Speculative grade" (1.50x to 3.00x), on lines anchored on Damodaran's interest-coverage table.

Year by year against peers: Whether Rentokil Initial plc's free cash flow conversion stayed above the median of the Industrials sector, year by year. (FY2019 to FY2025, 7 fiscal years of Rentokil Initial plc with a comparable figure)
The direction: Which way Rentokil Initial plc's interest coverage has moved, and how steadily. (FY2016 to FY2025, 10 filed years of Rentokil Initial plc)
What could explain it: What in Rentokil Initial plc's filed statements could explain the movements. (1 reading drawn from the statement lines Rentokil Initial plc filed)
What to check next: What to check next on Rentokil Initial plc, and where in its filings. (1 question for Rentokil Initial plc)
In one paragraph: One paragraph on Rentokil Initial plc's returns, cash, balance sheet and price. (5 of sixteen figures read for Rentokil Initial plc)

These are RTO’s filed figures. The research desk says what they mean, against peers and its own years, with what to check next.

Research RTOPart of Serious. New accounts start with 30 days of Professional, free, no card.

2 of 10

What changed

The newest filing, what it moved, and when the next one is due.

SEC filingCompany statement

The newest accounts on file are the FY2025 annual report: 20-F, filed Mar 25, 2026, accession 0001104659-26-034062.

3 of 10

Quality

The returns the business earns on its capital, and the margins behind them.

Computed

Rentokil Initial plc: returns on capital and margins, each with its source
Figure	Value, source and document
Return on invested capital, after tax Why n/a No annual statement of this kind is on file for this fiscal year.	n/a ComputedFY2025 20-F, filed Mar 25, 2026, 0001104659-26-034062
Return on equity Why n/a No annual statement of this kind is on file for this fiscal year.	n/a ComputedFY2025 20-F, filed Mar 25, 2026, 0001104659-26-034062
Return on capital employed, pre-tax Why n/a We do not hold this figure for this company, so there is nothing to show.	n/a ComputedFY2025 20-F, filed Mar 25, 2026, 0001104659-26-034062
Return on assets Why n/a We do not hold this figure for this company, so there is nothing to show.	n/a ComputedFY2025 20-F, filed Mar 25, 2026, 0001104659-26-034062
Gross margin Why n/a Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.	n/a ComputedFY2025 20-F, filed Mar 25, 2026, 0001104659-26-034062
Operating margin Why n/a Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.	n/a ComputedFY2025 20-F, filed Mar 25, 2026, 0001104659-26-034062
Net margin Why n/a Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.	n/a ComputedFY2025 20-F, filed Mar 25, 2026, 0001104659-26-034062

4 of 10

Financial strength

What it owes against what it owns, and whether it can meet what falls due.

SEC filingMarket dataComputedCompany statement

Rentokil Initial plc: leverage, liquidity and distress, each with its source
Figure	Value, source and document
Debt to equity Why n/a No annual statement of this kind is on file for this fiscal year.	n/a ComputedStatement not held
Current ratio Why n/a No annual statement of this kind is on file for this fiscal year.	n/a ComputedStatement not held
Quick ratio Why n/a We do not hold this figure for this company, so there is nothing to show.	n/a ComputedFY2025 20-F, filed Mar 25, 2026, 0001104659-26-034062
Interest coverage	2.34x ComputedFY2025 20-F, filed Mar 25, 2026, 0001104659-26-034062
Altman Z-score Why n/a Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.	n/a ComputedClose of Oct 15, 2026 · FY2025 20-F, filed Mar 25, 2026, 0001104659-26-034062
Net debt	3.23B ComputedFY2022 market data, supplied Oct 15, 2026, no SEC filing named, accession n/a

Total assets Total liabilities Shareholders’ equity

The balance sheet, line by line

Financial health

What Rentokil Initial plc owned and owed at the end of fiscal 2022, from a copy of its balance sheet that names no SEC filing (market data).

Rentokil Initial plc: balance sheet position
Total assets	11.92B Market dataFY2022 market data, supplied Oct 15, 2026, no SEC filing named
Total liabilities	7.82B Market dataFY2022 market data, supplied Oct 15, 2026, no SEC filing named
Shareholders' equity	4.10B Market dataFY2022 market data, supplied Oct 15, 2026, no SEC filing named
Cash	2.17B Market dataFY2022 market data, supplied Oct 15, 2026, no SEC filing named
Total debt	5.40B Market dataFY2022 market data, supplied Oct 15, 2026, no SEC filing named
Net debt	3.23B
Current ratio	n/a
Debt to equity	n/a

Debt to equity: FY2022: The figures on this page are FY2025's, and for FY2025 this ratio is n/a; this FY2022 figure is from another year's balance sheet, so it is not printed beside them.
Current ratio: FY2022: The figures on this page are FY2025's, and for FY2025 this ratio is n/a; this FY2022 figure is from another year's balance sheet, so it is not printed beside them.

Read from the filed balance sheet for each year, with the income statement of the same year supplying operating profit where a ratio needs it. Nothing here is a view on whether this company is sound.

5 of 10

Valuation context

What the market charges for it, against its own record and companies like it.

Market dataSEC filingComputed

Rentokil Initial plc: what the market charges, each with its source
Figure	Value, source and document
Price to earnings	22.29x ComputedClose of Oct 15, 2026 · FY2025 20-F, filed Mar 25, 2026, 0001104659-26-034062
P/E on trailing twelve months Why n/a A trailing figure needs 4 filed quarters with the dates they were filed on, and we hold 0 for this company. Nothing is drawn rather than a line built from fewer.	n/a ComputedClose of Oct 15, 2026 · Trailing four quarters, each as known on the day; the quarterly filings are listed under Filings
Price to book Why n/a We do not hold this figure for this company, so there is nothing to show.	n/a ComputedClose of Oct 15, 2026 · Statement not held
Price to sales Why n/a Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.	n/a ComputedClose of Oct 15, 2026 · FY2025 20-F, filed Mar 25, 2026, 0001104659-26-034062
Enterprise value to EBIT Why n/a We do not hold this figure for this company, so there is nothing to show.	n/a ComputedClose of Oct 15, 2026 · FY2025 20-F, filed Mar 25, 2026, 0001104659-26-034062
Enterprise value to EBITDA Why n/a We do not hold this figure for this company, so there is nothing to show.	n/a ComputedClose of Oct 15, 2026 · FY2025 20-F, filed Mar 25, 2026, 0001104659-26-034062
Price to earnings over growth Why n/a We do not hold this figure for this company, so there is nothing to show.	n/a ComputedClose of Oct 15, 2026 · FY2025 20-F, filed Mar 25, 2026, 0001104659-26-034062
Diluted earnings per share Why n/a The FY2025 filing carries no diluted earnings per share we could read.	n/a FiledFY2025 20-F, filed Mar 25, 2026, 0001104659-26-034062
Graham number Why n/a We do not hold this figure for this company, so there is nothing to show.	n/a ComputedFY2025 20-F, filed Mar 25, 2026, 0001104659-26-034062

We publish no fair value or price target of our own. Value RTO on your own assumptions in the DCF workbench, starting from the filed figures.

Its own record, and companies like it

Valuation

What the market charges for Rentokil Initial plc today, and the multiples it has carried. No value of ours: the figures are the filings’ and the market’s.

Rentokil Initial plc: valuation
Share price	20.82 USD
Market capitalisation	10.48B USD
Enterprise value to EBITDA	n/a
Graham number	n/a
Diluted earnings per share, FY2022	n/a

Price to earnings on trailing twelve months: A trailing figure needs 4 filed quarters with the dates they were filed on, and we hold 0 for this company. Nothing is drawn rather than a line built from fewer.

Companies like Rentokil Initial plc

Same industry (Specialty Business Services) and size band (Large, 10B to 200B), nearest in market value. Each of those counts equally, by how many of the companies considered sit between the two on it. Closest first: the order is likeness and nothing else.

6 of 10

Cash generation

Whether profit arrives as cash, and what is paid back to shareholders.

SEC filingComputed

Rentokil Initial plc: cash generation and what is paid out, each with its source
Figure	Value, source and document
Free cash flow yield	7.3% ComputedClose of Oct 15, 2026 · FY2025 20-F, filed Mar 25, 2026, 0001104659-26-034062
Free cash flow	764.0M USD ComputedFY2025 20-F, filed Mar 25, 2026, 0001104659-26-034062
Free cash flow margin Why n/a Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.	n/a ComputedFY2025 20-F, filed Mar 25, 2026, 0001104659-26-034062
Dividend yield	2.9% ComputedClose of Oct 15, 2026 · FY2025 20-F, filed Mar 25, 2026, 0001104659-26-034062
Payout ratio	64.7% ComputedFY2025 20-F, filed Mar 25, 2026, 0001104659-26-034062

Free cash flow Net incomeProfit that arrives as cash stands level with net income; a gap year after year is worth reading about.

7 of 10

Filings

Every figure, the year it is for and the document it was read from.

SEC filingMarket data

The filed figures

Computed from the accounts this company filed with the SEC and, in a ratio with a price in it, the last close, dated on this page. Every filed figure below carries the fiscal year and the filing date its accounts were read from, and every blank carries the reason it is blank. Nothing here is a view on this company.

Rentokil Initial plc: the eight ratios, with the fiscal year and filing date behind each.
Figure	Value	Year	As of
	22.29x	FY2025	Oct 15, 2026
FormulaShare price / earnings per share. Where the filing states no earnings per share this listing can be priced on, which is every 20-F and 40-F filer because theirs is stated per ordinary share, it is market capitalisation / net income: the same multiple, undiluted. As ofThe close on Oct 15, 2026, over the filed figures of FY2025: a price is in this figure, and it moved after the filing. Form20-FFiledMar 25, 2026PeriodFY2025Accession0001104659-26-034062What we read from itIncome statementFY2025Open on SEC.gov, accession 0001104659-26-034062, leaves this page and opens in a new tab
	n/a	n/a	Oct 15, 2026
n/a No balance sheet for the latest filed year is on file, or the one on file reports no total assets.
FormulaMarket capitalisation / shareholders equity As ofThe close on Oct 15, 2026, over the filed figures of n/a: a price is in this figure, and it moved after the filing.
	n/a	FY2025	Oct 15, 2026
n/a No balance sheet for the latest filed year is on file, or the one on file reports no total assets.
Formula(Market capitalisation + total debt - cash) / operating income, or over the filing's own EBIT (income before tax + interest expense) where the filer tags no operating line, as Johnson & Johnson does not in any of its ten filed years. As ofThe close on Oct 15, 2026, over the filed figures of FY2025: a price is in this figure, and it moved after the filing. Form20-FFiledMar 25, 2026PeriodFY2025Accession0001104659-26-034062What we read from itIncome statementFY2025Open on SEC.gov, accession 0001104659-26-034062, leaves this page and opens in a new tab
	7.3%	FY2025	Oct 15, 2026
FormulaFree cash flow per share / share price x 100 As ofThe close on Oct 15, 2026, over the filed figures of FY2025: a price is in this figure, and it moved after the filing. Form20-FFiledMar 25, 2026PeriodFY2025Accession0001104659-26-034062What we read from itCash flow statementFY2025Open on SEC.gov, accession 0001104659-26-034062, leaves this page and opens in a new tab
	n/a	FY2025	Mar 25, 2026
n/a No annual statement of this kind is on file for this fiscal year.
FormulaVendor trailing-twelve-month return on invested capital where one is published, which uses after-tax operating profit over total assets less current liabilities. Otherwise our own recompute: NOPAT / (shareholders equity + total debt - cash) x 100, where NOPAT is the filed operating profit after tax, or the filing's own EBIT after tax where the filer tags no operating line. As ofThe filing date of the statements below, for FY2025. Form20-FFiledMar 25, 2026PeriodFY2025Accession0001104659-26-034062What we read from itIncome statementFY2025Open on SEC.gov, accession 0001104659-26-034062, leaves this page and opens in a new tab
	2.9%	FY2025	Oct 15, 2026
FormulaCommon dividends paid in the latest filed year / market capitalisation x 100. n/a where the filing cannot support it: a special or first-year payment, a total that mixes preferred dividends, or a cash-flow statement over 15 months old. As ofThe close on Oct 15, 2026, over the filed figures of FY2025: a price is in this figure, and it moved after the filing. Form20-FFiledMar 25, 2026PeriodFY2025Accession0001104659-26-034062What we read from itCash flow statementFY2025Open on SEC.gov, accession 0001104659-26-034062, leaves this page and opens in a new tab
	n/a	n/a	n/a
n/a No annual statement of this kind is on file for this fiscal year.
FormulaTotal debt / shareholders equity As ofThe filing date of the statements below.
	n/a	n/a	n/a
n/a No annual statement of this kind is on file for this fiscal year.
FormulaCurrent assets / current liabilities As ofThe filing date of the statements below.
	n/a	FY2025	Oct 15, 2026
n/a Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.
FormulaMarket capitalisation / revenue As ofThe close on Oct 15, 2026, over the filed figures of FY2025: a price is in this figure, and it moved after the filing. Form20-FFiledMar 25, 2026PeriodFY2025Accession0001104659-26-034062What we read from itIncome statementFY2025Open on SEC.gov, accession 0001104659-26-034062, leaves this page and opens in a new tab
	n/a	FY2025	Oct 15, 2026
n/a The filed income statement reports no earnings per share.
FormulaPrice to earnings / the annual earnings growth rate, in percentage points As ofThe close on Oct 15, 2026, over the filed figures of FY2025: a price is in this figure, and it moved after the filing. Form20-FFiledMar 25, 2026PeriodFY2025Accession0001104659-26-034062What we read from itIncome statementFY2025Open on SEC.gov, accession 0001104659-26-034062, leaves this page and opens in a new tab
	n/a	FY2025	Oct 15, 2026
n/a Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.
Formula1.2 x working capital/assets + 1.4 x retained earnings/assets + 3.3 x EBIT/assets + 0.6 x market value of equity/total liabilities + 1.0 x revenue/assets As ofThe close on Oct 15, 2026, over the filed figures of FY2025: a price is in this figure, and it moved after the filing. Form20-FFiledMar 25, 2026PeriodFY2025Accession0001104659-26-034062What we read from itIncome statementFY2025Open on SEC.gov, accession 0001104659-26-034062, leaves this page and opens in a new tab
	n/a	FY2025	Mar 25, 2026
n/a Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.
FormulaAn eight-variable index of year-on-year changes in receivables, gross margin, asset quality, revenue, depreciation, overheads, leverage and accruals As ofThe filing date of the statements below, for FY2025. Form20-FFiledMar 25, 2026PeriodFY2025Accession0001104659-26-034062What we read from itIncome statementFY2025Open on SEC.gov, accession 0001104659-26-034062, leaves this page and opens in a new tabForm20-FFiledMar 25, 2026PeriodFY2025Accession0001104659-26-034062What we read from itCash flow statementFY2025Open on SEC.gov, accession 0001104659-26-034062, leaves this page and opens in a new tab
	n/a	FY2025	Mar 25, 2026
n/a Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.
FormulaOne point each for: positive return on assets, positive operating cash flow, rising return on assets, operating cash flow above net income, falling leverage, rising current ratio, no new shares issued, rising gross margin, rising asset turnover. As ofThe filing date of the statements below, for FY2025. Form20-FFiledMar 25, 2026PeriodFY2025Accession0001104659-26-034062What we read from itIncome statementFY2025Open on SEC.gov, accession 0001104659-26-034062, leaves this page and opens in a new tabForm20-FFiledMar 25, 2026PeriodFY2025Accession0001104659-26-034062What we read from itCash flow statementFY2025Open on SEC.gov, accession 0001104659-26-034062, leaves this page and opens in a new tab

The figures are computed from the accounts for fiscal 2025, the newest full year on file. 3 filed fiscal years on record, FY2023 to FY2025, from SEC EDGAR. Prices as of Oct 15, 2026. Ratios recomputed Oct 15, 2026. Two facts, because a recompute is not a fresh quote.

The year and the filing date name the statement each figure’s accounts are read from, and they stand even where the figure itself could not be computed: the line beneath a blank says what that statement did not carry. A figure’s name opens its formula and the filings behind it; a statement that names no SEC filing has no filing date, and reads n/a.

Ten years of filed figures, year by year

Ten years of filed figures

10 fiscal years, FY2016 to FY2025. 3 read from the annual reports Rentokil Initial plc filed with the SEC, each naming its filing; the rest from statements that name none, which are market data. Amounts in the currency each report was stated in.

Rentokil Initial plc: revenue, earnings, free cash flow and returns, by fiscal year, with the filing each year was read from
Year	Revenue	Operating income	Net income	EPS, diluted	Free cash flow	Operating margin	Return on equity	Filing
FY2025	n/a	584.0M USD	470.0M USD	n/a	764.0M USD	n/a	n/a	20-F, Mar 25, 20260001104659-26-034062
FY2024	n/a	644.0M USD	392.0M USD	n/a	649.0M USD	n/a	n/a	20-F, Mar 26, 20250001104659-25-027944
FY2023	n/a	727.0M USD	474.0M USD	n/a	709.0M USD	n/a	n/a	20-F, Mar 27, 20240001104659-24-039234
FY2022	3.71B GBP	317.0M GBP	232.0M GBP	0.60 GBP	414.0M GBP	8.5%	5.7%	Market data, supplied Oct 15, 2026accession n/a
FY2021	2.95B GBP	347.0M GBP	263.0M GBP	0.70 GBP	407.2M GBP	11.8%	20.8%	Market data, supplied Oct 15, 2026accession n/a
FY2020	2.79B GBP	294.0M GBP	186.0M GBP	0.50 GBP	382.6M GBP	10.5%	16.5%	Market data, supplied Oct 15, 2026accession n/a
FY2019	2.71B GBP	265.6M GBP	283.8M GBP	0.75 GBP	322.4M GBP	9.8%	28.3%	Market data, supplied Oct 15, 2026accession n/a
FY2018	2.47B GBP	245.5M GBP	-98.3M GBP	-0.27 GBP	216.4M GBP	9.9%	-11.8%	Market data, supplied Oct 15, 2026accession n/a
FY2017	2.41B GBP	292.4M GBP	682.8M GBP	1.85 GBP	205.5M GBP	12.1%	73.1%	Market data, supplied Oct 15, 2026accession n/a
FY2016	2.17B GBP	232.4M GBP	167.5M GBP	0.46 GBP	175.0M GBP	10.7%	46.5%	Market data, supplied Oct 15, 2026accession n/a

Revenue, compound annual growth FY2016 to FY2022: 9.4%
Earnings, compound annual growth FY2016 to FY2025: 12.1%
Earnings per share, compound annual growth FY2016 to FY2022: 4.5%
Free cash flow, compound annual growth FY2016 to FY2025: 17.8%

Every figure in this section is a line of a filed annual statement or a ratio of two of them. Nothing here is estimated or smoothed. Earnings per share filed before a share split are put on today's share count, and say so. Nothing here is a verdict on the company.

8 of 10

Risks and guardrails

The accounting screens, the published tests, and the lines you can set to be told.

ComputedCompany statement

Rentokil Initial plc: accounting screens and published tests, each with its source
Figure	Value, source and document
Beneish M-score Why n/a Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.	n/a ComputedFY2025 20-F, filed Mar 25, 2026, 0001104659-26-034062
Piotroski F-score Why n/a Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.	n/a ComputedFY2025 20-F, filed Mar 25, 2026, 0001104659-26-034062
Named tests met	1 of 30 Computed
Beta	0.81 ComputedClose of Oct 15, 2026

The named tests

Of 30 tests value investors published: 1 met, 8 not met, 21 we could not complete. Counts, never a score: a single figure would have to decide that meeting one investor’s criteria and meeting another’s are worth the same.

Which tests, by name(all 30)

Meets: Cash-covered dividend
Does not: Large cap, low P/E; EV/EBITDA and coverage; High yield, low payout; Low beta, profitable; Z-score and coverage (Edward Altman); Owner earnings yield; Cheapest quarter on P/E (David Dreman); Low P/E, growth, yield (John Neff)
Not measured: Defensive investor (Benjamin Graham); Deep value; Earnings yield and ROIC (Joel Greenblatt); High F-score, low P/B (Joseph Piotroski); Three forensic scores; Low PEG, low debt (Peter Lynch); High returns and growth; Gross margin, turnover (Robert Novy-Marx); Dividends and buybacks; ROIC at or above WACC; Near the 52-week low; Two thirds of NCAV (Benjamin Graham); P/E times P/B (Benjamin Graham); High returns, low debt; High return on tangibles; Low P/S, rising earnings (James O'Shaughnessy); Book or below, low debt (Walter Schloss); Tangible book or below; Cash-flow yield and ROIC; Clean books, high ROIC; Cheapest quarter on P/B (David Dreman). A test with a figure we could not read is incomplete, never met and never failed.

Figures we could not read(24)

Current Ratio: No annual statement of this kind is on file for this fiscal year.
Debt to Equity: No annual statement of this kind is on file for this fiscal year.
Positive Earnings Streak: The latest filed year has no per-share earnings we can read; the test needs 10.
P/B Ratio: We do not hold this figure for this company, so there is nothing to show.
Piotroski F-Score: Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.
EV/EBIT: We do not hold this figure for this company, so there is nothing to show.
Return on Invested Capital: No annual statement of this kind is on file for this fiscal year.
Altman Z-Score: Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.
Beneish M-Score: Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.
PEG Ratio: We do not hold this figure for this company, so there is nothing to show.
Eps Growth 5Y: We do not hold this figure for this company, so there is nothing to show.
Return on Equity: No annual statement of this kind is on file for this fiscal year.
Rev Growth 5Y: Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.
Gross Margin: Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.
Asset Turnover: Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.
EV/EBITDA: We do not hold this figure for this company, so there is nothing to show.
Share Count Change Yoy: We do not hold this figure for this company, so there is nothing to show.
ROIC-WACC Spread: We do not hold this figure for this company, so there is nothing to show.
Price To Ncav: We do not hold this figure for this company, so there is nothing to show.
Price To Graham: We do not hold this figure for this company, so there is nothing to show.
Return Tangible: We do not hold this figure for this company, so there is nothing to show.
P/S Ratio: Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.
Price Tangible Book: We do not hold this figure for this company, so there is nothing to show.
Tangible Equity Ratio: We do not hold this figure for this company, so there is nothing to show.

9 of 10

Declared positions

Whether anybody here owns this company.

Positions declared by the founder: no holding in any company shown here, as of October 3, 2026.

10 of 10

Next step

What to do with what you have read.

Value it in the DCF workbench

A thesis is your reason for owning it, in your words, with the figures that must stay true. Checking those figures every night against the newest filed accounts, and telling you once when one breaks, is what the subscription adds.

What this cannot tell you

24 figures could not be read on this company, among them Current Ratio, Debt to Equity, Positive Earnings Streak. Each blank in the table above names the rest, with its reason. 21 named tests come back incomplete because of them, which is neither met nor missed.
We hold 3 filed fiscal years rather than 10, so the run above is shorter than a full decade and is counted as what it is.

And the one that is true of all of it: This is what the numbers say today. It cannot tell you the day one of them stops being true. Nothing here can, because the reasons are not written down.

Running this once is arithmetic on public documents and you are welcome to it. Writing down why you own each company, in your own words and with the numbers that have to stay true for it to hold, and then having those numbers re-checked every night against the newest filed accounts, and against the latest close where a rule watches a price, is Professional, the plan a new account starts on for 30 days, one trial per person. It writes to you the day one breaks, and stays quiet when nothing does. The check runs every night at 23:30 UTC. A filing is picked up the night after it is published.

Monitor my portfolio How this is computed

No card. 30 free days, and nothing is charged unless you choose a plan.

Analyze your own portfolio

ValueScreener · valuescreener.ai · Computed from accounts filed with the SEC by this company, read from EDGAR, and from dated closing prices. On this page a filed figure opens into its formula, its inputs and the statement, fiscal year and filing date it was read from, and a price into the day of its close. A figure that cannot show that trail says so.

A computation on accounts filed with the SEC, not a recommendation and not advice. Past filings do not indicate future results. Risk disclaimer.

Four questions, at a glance

Quality

Financial strength

Valuation

Cash generation

Revenue and net income, by fiscal year

The reading, in brief

Financial health

Valuation

Companies like Rentokil Initial plc

The filed figures

Ten years of filed figures

The named tests

What this cannot tell you

Margin Notes